Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction

被引:32
|
作者
Aaron, Shawn D. [1 ]
Tan, Wan C. [2 ]
Bourbeau, Jean [3 ]
Sin, Don D. [2 ]
Loves, Robyn H. [1 ]
MacNeil, Jenna [1 ]
Whitmore, George A. [1 ,4 ]
机构
[1] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[3] McGill Univ, Dept Med, Fac Med, Montreal, PQ, Canada
[4] McGill Univ, Desautels Fac Management, Montreal, PQ, Canada
关键词
chronic obstructive pulmonary disease; diagnosis; lung function variability; spirometry; LUNG-FUNCTION; COPD; HEALTH; PREVALENCE; POLLUTION; EXPOSURE; CANCOLD; CARE; BOLD;
D O I
10.1164/rccm.201612-2531OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Chronic obstructive pulmonary disease (COPD) is a chronic, progressive disease, and reversal of COPD diagnosis is thought to be uncommon. Objectives: To determine whether a spirometric diagnosis of mild or moderate COPD is subject to variability and potential error. Methods: We examined two prospective cohort studies that enrolled subjects with mild to moderate post-bronchodilator airflow obstruction. The Lung Health Study (n = 5,861 subjects; study duration, 5 yr) and the Canadian Cohort of Obstructive Lung Disease(CanCOLD) study (n = 1,551 subjects; study duration, 4 yr) were examined to determine frequencies of (1) diagnostic instability, represented by how often patients initially met criteria for a spirometric diagnosis of COPD but then crossed the diagnostic threshold to normal and then crossed back to COPD over a series of annual visits, or vice versa; and (2) diagnostic reversals, defined as how often an individual's COPD diagnosis at the study outset reversed to normal by the end of the study. Measurements and Main Results: Diagnostic instability was common and occurred in 19.5% of the Lung Health Study subjects and 6.4% of the CanCOLD subjects. Diagnostic reversals of COPD from the beginning to the end of the study period occurred in 12.6% and 27.2% of subjects in the Lung Health Study and CanCOLD study, respectively. The risk of diagnostic instability was greatest for subjects whose baseline FEV1/FVC value was closest to the diagnostic threshold, and the risk of diagnostic reversal was greatest for subjects who quit smoking during the study. Conclusions: A single post-bronchodilator spirometric assessment may not be reliable for diagnosing COPD in patients with mild to moderate airflow obstruction at baseline.
引用
收藏
页码:306 / 314
页数:9
相关论文
共 50 条
  • [1] Airflow obstruction and chronic obstructive pulmonary disease in pulmonary tuberculosis
    Lee, Jaeuk
    Park, Hye Jung
    Byun, Min Kwang
    Kim, Chi Young
    Shin, Sojung
    Kim, Youlim
    Rhee, Chin Kook
    Jung, Ki Suck
    Yoo, Kwang Ha
    RESPIROLOGY, 2023, 28 : 273 - 274
  • [2] Subtypes of Patients with Mild to Moderate Airflow Limitation as Predictors of Chronic Obstructive Pulmonary Disease Exacerbation
    Kim, Nam Eun
    Kang, Eun-Hwa
    Jung, Ji Ye
    Lee, Chang Youl
    Lee, Won Yeon
    Lim, Seong Yong
    Park, Dong Il
    Yoo, Kwang Ha
    Jung, Ki-Suck
    Lee, Jin Hwa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [3] A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease
    Sogbetun, Folarin
    Eschenbacher, William L.
    Welge, Jeffrey A.
    Panos, Ralph J.
    RESPIRATORY MEDICINE, 2016, 120 : 1 - 9
  • [4] Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction
    Martinez, Fernando J.
    Vestbo, Jorgen
    Anderson, Julie A.
    Brooke, Robert D.
    Celli, Bartolome R.
    Cowans, Nicholas J.
    Crim, Courtney
    Dransfield, Mark
    Kilbride, Sally
    Yates, Julie
    Newby, David E.
    Niewoehner, Dennis
    Calverley, Peter M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (07) : 881 - 888
  • [5] Clinical significance of normalized airflow obstruction in patients with chronic obstructive pulmonary disease
    Kim, Yun Seok
    Hwang, Yong Il
    Lee, Jae Ha
    Park, Yong Bum
    Choi, Cheon Woong
    Jung, Ki-Suck
    Yoo, Kwang Ha
    Lim, Seong Yong
    Kim, Ju Sang
    Choi, Joon Young
    RESPIRATORY MEDICINE, 2023, 218
  • [6] Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease
    Caram, Laura
    Ferrari, Renata
    Bertani, Andre
    Garcia, Thais
    Bonfanti, Carolina
    Knaut, Caroline
    Tanni, Suzana
    Correa, Camila
    Godoy, Irma
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] The Lung Tissue Microbiota In Mild Or Moderate Chronic Obstructive Pulmonary Disease
    Pragman, A. A.
    Baller, J. A.
    Reilly, C.
    Isaacson, R. E.
    Wendt, C. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [8] The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease
    Alexa A. Pragman
    Tianmeng Lyu
    Joshua A. Baller
    Trevor J. Gould
    Rosemary F. Kelly
    Cavan S. Reilly
    Richard E. Isaacson
    Chris H. Wendt
    Microbiome, 6
  • [9] The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease
    Pragman, Alexa A.
    Lyu, Tianmeng
    Baller, Joshua A.
    Gould, Trevor J.
    Kelly, Rosemary F.
    Reilly, Cavan S.
    Isaacson, Richard E.
    Wendt, Chris H.
    MICROBIOME, 2018, 6
  • [10] Utility of chronic obstructive pulmonary disease assessment test in perioperative assessment of patients with mild to moderate chronic obstructive pulmonary disease
    Lee, Bora
    Ji, Wonjun
    Lee, Sei Won
    Choi, Chang-Min
    Oh, Yeon-Mok
    Lee, Jae Seung
    JOURNAL OF THORACIC DISEASE, 2024, 16 (10)